Strides Pharma Science Reports Over 50% Profit Rise in Q1 with Revenue Growth
Strides Pharma Science Ltd reported a significant increase in its first-quarter profit after tax, rising approximately 57% to around Rs 156-165 crore for the quarter ending June 30. Revenue grew by about 13% to Rs 1,265 crore, driven by strong growth in markets outside the US, which saw a 17% year-on-year increase. The US market remained steady with a modest 4% rise. Despite elevated operating and freight costs due to geopolitical factors, the company’s EBITDA improved by around 5%, supported by ongoing cost optimization efforts.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (66/100). Lens Score 33/100.
Outlets measured: businessstandard, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (65–68/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 31 Jul, 08:30 am. Other outlets followed.
- 1